Table 7 Summary of studies on the role of extracellular vesicles in lung fibrosis.
EVs source | Target cells or tissues | Animal model | Molecular mechanism | Action effect | Ref |
---|---|---|---|---|---|
BMSC-Exos | Lung macrophage | Hyperoxia-induced BPD | Suppress M1 macrophage production and enhance M2 macrophage generation | Improve lung function, decrease fibrosis and pulmonary vascular remodeling, and ameliorate pulmonary hypertension. | [144] |
hBMSC-Exos | Lung macrophage | Bleomycin-induced pulmonary fibrosis | Regulate total lung imbalance of macrophage phenotype | Prevent or reverse lung fibrosis | [145] |
UC-MSC-Exos | PAEC and PASMC | Monocrotaline-induced rat model of PH | Regulate Wnt5a/BMP signaling pathway | Attenuate pulmonary vascular remodeling and lung fibrosis | [146] |
UC-MSC-Exos | Lung tissue | BPD | Immunomodulatory glycoprotein TSG-6 | Improve pulmonary inflammation, pulmonary simplification, pulmonary hypertension, and right ventricular hypertrophy | [147] |
BMSC-EVs | IPF pulmonary tissue | IPF | MiR‐29b‐3p | Ameliorate IPF | [148] |
BMSC-EVs | Lung fibroblast | PF | MiR-186 suppressed SOX4 and DKK1 expression, blocked fibroblast activation | Ameliorate IPF | [149] |
hPMSC -EVs | Lung fibroblast | Whole thorax irradiation mouse model | MiR-214-3p downregulate ATM/P53/P21 signaling | Relieve radiation-induced lung inflammation and fibrosis | [150] |
MenSCs-Exos | Recipient alveolar epithelial cells | BLM | MiRNA Let-7 suppresses ROS, mtDNA damage, and NLRP3 inflammasome activation | Remit pulmonary fibrosis | [151] |
MSC-Exos | MLE-12 cells* | LPS-induced ALI | Transmit miR-23a-3p and miR-182-5p to inhibit NF-κB and hedgehog pathways | Reversed the LPS-induced lung injury and fibrosis | [152] |